ADVFN US – Market Content Editor

  • Sagtec Global plans NVIDIA-powered data center targeted for completion by Q4 2026

    Sagtec Global plans NVIDIA-powered data center targeted for completion by Q4 2026

    Sagtec Global Limited (NASDAQ:SAGT) announced plans to develop a new data center powered by NVIDIA GPU architecture through its subsidiary CL Technologies (International) Sdn Bhd. The facility is expected to be completed in the fourth quarter of 2026. The Malaysia-based technology company said the new infrastructure will be designed to handle millions of daily transactions…

  • Velo3D shares rise after securing $9.8M defense manufacturing contract

    Velo3D shares rise after securing $9.8M defense manufacturing contract

    Velo3D, Inc. (NASDAQ:VELO) shares climbed about 10% on Monday after the company announced it had been awarded a $9.8 million contract spanning five years with the Defense Logistics Agency. The metal additive manufacturing firm said the agreement is structured as an Indefinite Delivery Indefinite Quantity contract tied to the Defense Logistics Agency’s Joint Additive Manufacturing…

  • Flowers Foods to Eliminate Chief Growth Officer Position

    Flowers Foods to Eliminate Chief Growth Officer Position

    Flowers Foods Inc. (NYSE:FLO) announced that Terry Thomas will step down from his role as chief growth officer, with the company also confirming that the position will be discontinued. The role was introduced in 2023 as part of an effort to strengthen the company’s growth strategy and develop new capabilities. Thomas will remain with the…

  • Bargain Hunting May Spark Early Rebound on Wall Street: Dow Jones, S&P, Nasdaq, Futures

    Bargain Hunting May Spark Early Rebound on Wall Street: Dow Jones, S&P, Nasdaq, Futures

    U.S. stock futures are pointing to a higher open on Monday, suggesting equities may recover some of the ground lost during last week’s sharp sell-off. Early gains could be driven by bargain hunting, as some investors take advantage of lower valuations following the recent market weakness. The downturn last week pushed the major U.S. indices…

  • Vertical Aerospace shares jump after announcing $800M funding package

    Vertical Aerospace shares jump after announcing $800M funding package

    Shares of Vertical Aerospace Ltd. (NYSE:EVTL) climbed about 16% on Monday after the company revealed plans for a financing package that could total up to $800 million. The company said on March 30, 2026, that it had reached an agreement in principle for the funding arrangement, which includes three financing components provided by two investment…

  • Viridian shares plunge despite positive Phase 3 trial results

    Viridian shares plunge despite positive Phase 3 trial results

    Shares of Viridian Therapeutics (NASDAQ:VRDN) dropped about 40% on Monday after the company released topline data from its Phase 3 REVEAL-1 study of elegrobart in patients with active thyroid eye disease, even though the treatment met its primary endpoint. The trial produced a highly statistically significant treatment effect. Patients receiving elegrobart every four weeks (Q4W)…

  • Neumora tops Q4 earnings forecasts as pipeline advances, shares slip

    Neumora tops Q4 earnings forecasts as pipeline advances, shares slip

    Neumora Therapeutics, Inc. (NASDAQ:NMRA) on Monday reported fourth-quarter results that came in ahead of analyst estimates. Despite the earnings beat, the company’s stock declined about 2.15% in premarket trading as investors assessed its cash position and ongoing pipeline developments. The clinical-stage biopharmaceutical company posted a quarterly loss of $0.35 per share, outperforming the analyst consensus…

  • Connect Biopharma shares jump after encouraging clinical data

    Connect Biopharma shares jump after encouraging clinical data

    Shares of Connect Biopharma Holdings Limited (NASDAQ:CNTB) climbed about 11% after the company released positive findings from several clinical studies evaluating rademikibart, its anti-interleukin-4-receptor alpha antibody. The company reported preliminary results from a Phase 1 clinical pharmacology trial showing that a single 300 mg intravenous dose of rademikibart, delivered via a two-minute IV push, produced…

  • Anavex withdraws EU approval filing for Alzheimer’s therapy

    Anavex withdraws EU approval filing for Alzheimer’s therapy

    Anavex Life Sciences Corp. (NASDAQ:AVXL) has withdrawn its application seeking marketing authorization in the European Union for blarcamesine as a treatment for early-stage Alzheimer’s disease, the company said. The biopharmaceutical group noted that discussions with the European Medicines Agency are ongoing as it works to address issues raised by the Committee for Medicinal Products for…

  • Roma Green Finance shares jump after $100M buyback authorization

    Roma Green Finance shares jump after $100M buyback authorization

    Shares of Roma Green Finance (NASDAQ:ROMA) soared about 35% after the company unveiled plans for a $100 million share repurchase program. The ESG and sustainability advisory firm said its board of directors approved the buyback initiative, which will run through December 31, 2028. Roma Green Finance currently has a market capitalization of roughly $375 million.…